Skip to main content
. 2019 Aug 2;11(8):1106. doi: 10.3390/cancers11081106

Figure 5.

Figure 5

Kaplan–Meier survival analysis regarding HLA-GEV status for patients without residual tumor burden. Kaplan–Meier analysis combined with log-rank test demonstrated that high levels of HLA-GEV are significantly associated with a reduced 10-year PFS in patients without residual tumor burden. The red line represents patients with HLA-GEV levels greater than 18.45 ng/mL, whereas the black line illustrates patients with HLA-GEV levels less than 18.45 ng/mL. The dotted lines indicate median survival time. Tables under Kaplan–Meier plots show the corresponding numbers at risk.